Aiforia Technologies Oyj Past Earnings Performance
Past criteria checks 0/6
Aiforia Technologies Oyj's earnings have been declining at an average annual rate of -33.2%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 40.2% per year.
Key information
-33.2%
Earnings growth rate
101.0%
EPS growth rate
| Healthcare Services Industry Growth | 7.9% |
| Revenue growth rate | 40.2% |
| Return on equity | -56.6% |
| Net Margin | -440.0% |
| Next Earnings Update | 14 Mar 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Aiforia Technologies Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 3 | -12 | 0 | 0 |
| 31 Mar 24 | 3 | -13 | 0 | 0 |
| 31 Dec 23 | 2 | -13 | 0 | 0 |
| 30 Sep 23 | 2 | -14 | 0 | 0 |
| 30 Jun 23 | 2 | -14 | 0 | 0 |
| 31 Mar 23 | 2 | -13 | 0 | 0 |
| 31 Dec 22 | 2 | -12 | 0 | 0 |
| 30 Sep 22 | 1 | -11 | 0 | 0 |
| 30 Jun 22 | 1 | -10 | 0 | 0 |
| 31 Mar 22 | 1 | -9 | 0 | 0 |
| 31 Dec 21 | 1 | -8 | 0 | 0 |
| 30 Sep 21 | 1 | -6 | 0 | 0 |
| 30 Jun 21 | 1 | -4 | 0 | 0 |
| 31 Mar 21 | 1 | -3 | 0 | 0 |
| 31 Dec 20 | 1 | -3 | 0 | 0 |
| 31 Dec 19 | 1 | -3 | 0 | 0 |
| 31 Dec 18 | 0 | -2 | 0 | 0 |
Quality Earnings: L6J is currently unprofitable.
Growing Profit Margin: L6J is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: L6J is unprofitable, and losses have increased over the past 5 years at a rate of 33.2% per year.
Accelerating Growth: Unable to compare L6J's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: L6J is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).
Return on Equity
High ROE: L6J has a negative Return on Equity (-56.59%), as it is currently unprofitable.